Does DENOSUMAB Cause Central venous catheterisation? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Central venous catheterisation have been filed in association with DENOSUMAB (Bilprevda). This represents 0.0% of all adverse event reports for DENOSUMAB.
6
Reports of Central venous catheterisation with DENOSUMAB
0.0%
of all DENOSUMAB reports
0
Deaths
4
Hospitalizations
How Dangerous Is Central venous catheterisation From DENOSUMAB?
Of the 6 reports, 4 (66.7%) required hospitalization.
Is Central venous catheterisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DENOSUMAB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does DENOSUMAB Cause?
Off label use (34,612)
Death (16,545)
Osteonecrosis of jaw (8,438)
Arthralgia (5,890)
Pain in extremity (4,541)
Back pain (4,465)
Pain (4,102)
Product storage error (3,621)
Fall (3,322)
Fatigue (3,009)
What Other Drugs Cause Central venous catheterisation?
EPOPROSTENOL (361)
AMBRISENTAN (263)
TREPROSTINIL (208)
ECULIZUMAB (105)
VENETOCLAX (89)
MACITENTAN (78)
PEMBROLIZUMAB (70)
AZTREONAM LYSINE (63)
ADALIMUMAB (59)
NATALIZUMAB (57)
Which DENOSUMAB Alternatives Have Lower Central venous catheterisation Risk?
DENOSUMAB vs DEOXYCHOLIC ACID
DENOSUMAB vs DEPAKINE CHRONO
DENOSUMAB vs DEPAKOTE
DENOSUMAB vs DEPO-PROVERA
DENOSUMAB vs DERMATOPHAGOIDES FARINAE